Fujimoto J, Okamoto E, Yamanaka N, Oriyama T, Furukawa K, Kawamura E
First Department of Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
Nihon Geka Gakkai Zasshi. 1991 Sep;92(9):1307-11.
Flow cytometric DNA analysis was done on 302 resected hepatocellular carcinoma and 30 specimens by fine needle aspiration biopsy. Patients with DNA aneuploid tumors had a significant worse prognosis than those with DNA diploid tumors in subdivided groups by curability (p less than 0.01). The recurrence after hepatectomy occurred frequently in DNA aneuploid or non-curative resected group. In a cox multivariate analysis, nuclear DNA content provided significant prognostic value (p = 0.008) as did vascular invasion and intrahepatic metastasis. For the multiple tumors of hepatocellular carcinoma, it is helpful to get the DNA ploidy pattern to diagnose tumors with intrahepatic metastasis or multicentric origin. Nuclear DNA analysis by fine needle aspiration biopsy was useful to determine the treatment method of hepatocellular carcinoma.
对302例手术切除的肝细胞癌和30例细针穿刺活检标本进行了流式细胞术DNA分析。在按可治愈性细分的组中,DNA非整倍体肿瘤患者的预后明显比DNA二倍体肿瘤患者差(p<0.01)。肝切除术后复发在DNA非整倍体或非根治性切除组中频繁发生。在Cox多因素分析中,核DNA含量与血管侵犯和肝内转移一样,具有显著的预后价值(p = 0.008)。对于肝细胞癌的多发肿瘤,获取DNA倍体模式有助于诊断有肝内转移或多中心起源的肿瘤。细针穿刺活检的核DNA分析有助于确定肝细胞癌的治疗方法。